4-氟苯基异氰酸酯 | 24075-34-1

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-氟苯基异氰酸酯
• 中文别名: 4-氟异氰酸苯酯；1-氟-4-异氰基苯
• 英文名称: 4-fluorophenyl isocyanide
• 英文别名: 1-fluoro-4-isocyanobenzene；p-fluorophenylisocyanide；p-fluorophenyl isonitrile；p-Fluorphenylisocyanid
• CAS: 24075-34-1
• 化学式: C₇H₄FN
• mdl: MFCD04117575
• 分子量: 121.114
• InChiKey: FEUHGXVGNQTPGQ-UHFFFAOYSA-N

物化性质

• 沸点：
  62-68 °C
• 密度：
  1.19
• 稳定性/保质期：
  遵照规定使用和储存，则不会分解。

计算性质

• 辛醇/水分配系数(LogP)：
  2.1
• 重原子数：
  9
• 可旋转键数：
  0
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  4.4
• 氢给体数：
  0
• 氢受体数：
  2

安全信息

• 危险品标志：
  Xn
• 安全说明：
  S26,S36,S37,S39
• 危险类别码：
  R36/37/38
• 储存条件：
  存于阴凉干燥处

SDS

Name:	4-Fluorophenyl isocyanide 95% Material Safety Data Sheet
Synonym:
CAS:	24075-34-1

Section 1 - Chemical Product MSDS Name:4-Fluorophenyl isocyanide 95% Material Safety Data Sheet
Synonym:

---

Section 2 - COMPOSITION, INFORMATION ON INGREDIENTS

CAS#	Chemical Name	content	EINECS#
24075-34-1	4-Fluorophenyl isocyanide	95%	unlisted

Hazard Symbols: XN
Risk Phrases: 20/21/22 36/37/38

---

Section 3 - HAZARDS IDENTIFICATION
EMERGENCY OVERVIEW
Harmful by inhalation, in contact with skin and if swallowed.
Irritating to eyes, respiratory system and skin.
Potential Health Effects
Eye:
Causes eye irritation.
Skin:
Causes skin irritation. Harmful if absorbed through the skin.
Ingestion:
Harmful if swallowed. May cause irritation of the digestive tract.
Inhalation:
Harmful if inhaled. Causes respiratory tract irritation.
Chronic:
Not available.

---

Section 4 - FIRST AID MEASURES
Eyes: Flush eyes with plenty of water for at least 15 minutes, occasionally lifting the upper and lower eyelids. Get medical aid.
Skin:
Get medical aid. Flush skin with plenty of water for at least 15 minutes while removing contaminated clothing and shoes.
Ingestion:
Get medical aid. Wash mouth out with water.
Inhalation:
Remove from exposure and move to fresh air immediately. If not breathing, give artificial respiration. If breathing is difficult, give oxygen. Get medical aid.
Notes to Physician:
Treat symptomatically and supportively.

---

Section 5 - FIRE FIGHTING MEASURES
General Information:
As in any fire, wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. Will burn if involved in a fire.
Extinguishing Media:
Use water spray, dry chemical, carbon dioxide, or chemical foam.

---

Section 6 - ACCIDENTAL RELEASE MEASURES
General Information: Use proper personal protective equipment as indicated in Section 8.
Spills/Leaks:
Absorb spill with inert material (e.g. vermiculite, sand or earth), then place in suitable container.

---

Section 7 - HANDLING and STORAGE
Handling:
Avoid breathing dust, vapor, mist, or gas. Avoid contact with skin and eyes.
Storage:
Store in a cool, dry place. Store in a tightly closed container.

---

Section 8 - EXPOSURE CONTROLS, PERSONAL PROTECTION
Engineering Controls:
Facilities storing or utilizing this material should be equipped with an eyewash facility and a safety shower. Use adequate ventilation to keep airborne concentrations low.
Exposure Limits CAS# 24075-34-1: Personal Protective Equipment Eyes: Not available.
Skin:
Wear appropriate protective gloves to prevent skin exposure.
Clothing:
Wear appropriate protective clothing to prevent skin exposure.
Respirators:
Follow the OSHA respirator regulations found in 29 CFR 1910.134 or European Standard EN 149. Use a NIOSH/MSHA or European Standard EN 149 approved respirator if exposure limits are exceeded or if irritation or other symptoms are experienced.

---

Section 9 - PHYSICAL AND CHEMICAL PROPERTIES

Physical State: Solid
Color: brown
Odor: unpleasant odor
pH: Not available.
Vapor Pressure: Not available.
Viscosity: Not available.
Boiling Point: 62 - 68 deg C
Freezing/Melting Point: Not available.
Autoignition Temperature: Not available.
Flash Point: Not available.
Explosion Limits, lower: Not available.
Explosion Limits, upper: Not available.
Decomposition Temperature:
Solubility in water: Insoluble.
Specific Gravity/Density: 1.190
Molecular Formula: C7H4FN
Molecular Weight: 121.11

---

Section 10 - STABILITY AND REACTIVITY
Chemical Stability:
Not available.
Conditions to Avoid:
Incompatible materials.
Incompatibilities with Other Materials:
Strong oxidizing agents.
Hazardous Decomposition Products:
Carbon monoxide, oxides of nitrogen, carbon dioxide, hydrogen fluoride gas.
Hazardous Polymerization: Has not been reported

---

Section 11 - TOXICOLOGICAL INFORMATION
RTECS#:
CAS# 24075-34-1 unlisted.
LD50/LC50:
Not available.
Carcinogenicity:
4-Fluorophenyl isocyanide - Not listed by ACGIH, IARC, or NTP.

---

Section 12 - ECOLOGICAL INFORMATION

---

Section 13 - DISPOSAL CONSIDERATIONS
Dispose of in a manner consistent with federal, state, and local regulations.

---

Section 14 - TRANSPORT INFORMATION

IATA
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.*
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
IMO
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing Group: III
RID/ADR
Shipping Name: TOXIC LIQUID, ORGANIC, N.O.S.
Hazard Class: 6.1
UN Number: 2810
Packing group: III

---

Section 15 - REGULATORY INFORMATION

European/International Regulations
European Labeling in Accordance with EC Directives
Hazard Symbols: XN
Risk Phrases:
R 20/21/22 Harmful by inhalation, in contact with
skin and if swallowed.
R 36/37/38 Irritating to eyes, respiratory system
and skin.
Safety Phrases:
S 26 In case of contact with eyes, rinse immediately
with plenty of water and seek medical advice.
S 36/37/39 Wear suitable protective clothing, gloves
and eye/face protection.
WGK (Water Danger/Protection)
CAS# 24075-34-1: No information available.
Canada
None of the chemicals in this product are listed on the DSL/NDSL list.
CAS# 24075-34-1 is not listed on Canada's Ingredient Disclosure List.
US FEDERAL
TSCA
CAS# 24075-34-1 is not listed on the TSCA inventory.
It is for research and development use only.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  4-氟苯基异氰酸酯 在 1,2,3,4,5,6,7,8-八硫杂环辛烷 、 ammonium hydroxide 、 五甲基二乙烯三胺 作用下， 以 水 为溶剂， 反应 0.5h， 生成 1-(4-氟苯基)-2-硫脲
  参考文献：
  名称：

  在水性条件下使用元素硫方便地多组分一锅法合成 2-亚氨基噻唑啉和 2-氨基噻唑

  摘要：

  多组分一锅法导致在水性条件下形成多种三取代的 2-亚氨基噻唑啉和二取代的 2-氨基噻唑。从异氰化物、胺、2'-溴苯乙酮和多硫化物水溶液或硫粉开始，这种高效的程序能够实现固体产品的无色谱分离。

  DOI：

  10.1002/ejoc.202100548
• 作为产物：
  描述：

  碳亚胺二氯化,(4-氟苯基)- 在 lithium perchlorate 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以87%的产率得到4-氟苯基异氰酸酯
  参考文献：
  名称：

  烷基和芳基异氰酸酯的电化学生成

  摘要：

  已经建立了一种有效且广泛适用的无试剂合成烷基和芳基异氰酸酯的方法。在恒定的阴极电势下，烷基和芳基碳亚氨基二氯的电化学还原反应以几乎定量的产率得到相应的异氰化物。起始原料的可用性，反应条件的温和性以及产物的容易分离是该方法的值得注意的有利特征。

  DOI：

  10.1016/s0040-4020(99)00509-8

文献信息

• [EN] SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS<br/>[FR] COMPOSÉS TÉTRAHYDROISOQUINOLINES SUBSTITUÉS EN TANT QU'INHIBITEURS DU FACTEUR XIA
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2013055984A1

  公开（公告）日：2013-04-18

  The present invention provides compounds of Formula (I): or stereoisomers, pharmaceutically acceptable salts thereof, wherein all of the variables are as defined herein. These compounds are inhibitors of factor XIa and/or plasma kallikrein which may be used as medicaments.

  本发明提供了化合物的公式(I)：或其立体异构体，以及其药学上可接受的盐，其中所有变量如本文所定义。这些化合物是XIa因子和/或血浆激肽酶的抑制剂，可用作药物。
• PYRROLO AND PYRAZOLOPYRIMIDINES AS UBIQUITIN-SPECIFIC PROTEASE 7 INHIBITORS
  申请人：Forma Therapeutics, Inc.

  公开号：US20160185785A1

  公开（公告）日：2016-06-30

  The invention relates to inhibitors of USP7 inhibitors useful in the treatment of cancers, neurodegenerative diseases, immunological disorders, inflammatory disorders, cardiovascular diseases, ischemic diseases, viral infections and diseases, and bacterial infections and diseases, having the Formula: where m, n, X 1 , X 2 , R 1 -R 5 , R 5′ and R 6 are described herein.

  这项发明涉及USP7抑制剂，用于治疗癌症、神经退行性疾病、免疫紊乱、炎症性疾病、心血管疾病、缺血性疾病、病毒感染和疾病、细菌感染和疾病，具有以下结构式： 其中m、n、X1、X2、R1-R5、R5'和R6如本文所述。
• Synthesis and biological assays of E-ring analogs of camptothecin and homocamptothecin
  作者：R TANGIRALA、S ANTONY、K AGAMA、Y POMMIER、B ANDERSON、R BEVINS、D CURRAN

  DOI：10.1016/j.bmc.2006.05.073

  日期：2006.9.15

  Analogs of the anti-tumor agent camptothecin with both closed E-rings (lactone and ether) and open E-rings (reduced acid, hydrazide, and protected Weinreb amide) have been prepared and tested in topoisomerase and cellular assays. The results provide insights into the structural features of the camptothecin E-ring that affect biological activity.

  已经制备了具有封闭的E环（内酯和醚）和开放的E环（还原酸，酰肼和受保护的Weinreb酰胺）的抗肿瘤剂喜树碱的类似物，并在拓扑异构酶和细胞分析中进行了测试。结果为喜树碱E环影响生物活性的结构特征提供了见识。
• Letrozole production process
  申请人：Friedman Oded

  公开号：US20070112202A1

  公开（公告）日：2007-05-17

  Provided is a method for preparing letrozole, which includes reacting an activated bis-(4-cyanophenyl)-methane with a triazole to produce letrozole, and, optionally, purifying the letrozole. Also provided are highly pure letrozole, and a method of purifying letrozole, which method includes precipitating letrozole, e.g., by selective precipitation from a reaction mixture and/or by subjecting the letrozole to one or more crystallizations.

  提供了一种制备来曲唑的方法，该方法包括将激活的双-(4-氰基苯基)-甲烷与三唑反应以来曲唑，以及可选地纯化来曲唑。还提供了高纯度的来曲唑，以及一种纯化来曲唑的方法，该方法包括沉淀来曲唑，例如通过从反应混合物中选择性沉淀和/或将来曲唑进行一个或多个结晶。
• Thermal oligomerisation of aryl isocyanides: formation of pyrazino[1,2-a:4,5-a′]diindoles and indigo diarylimines
  作者：Jan C. A. Boeyens、Leanne M. Cook、Yunxiang Ding、Manuel A. Fernandes、David H. Reid

  DOI：10.1039/b302340k

  日期：——

  The aryl isocyanides 1–4 are converted at 150 °C into the hexameric pyrazino[1,2-a:4,5-a′]diindoles 15–19. 4-Fluorophenyl isocyanide, when heated at 135 °C, gave the hexamer 19 and the tetrameric indigo di-arylimine 9, and when kept at ambient temperature gave mainly the tetramer 9 in low yield. The structures of the hexamer 19 and the tetramer 9 were established by X-ray crystallography. Mechanisms are proposed for the oligomerisation reactions.

  将苯基异氰化合物1～4在150℃下转化为六聚吡嗪[1,2-a:4,5-a']二吲哚15～19。4-氟苯基异氰在135℃加热时得到六聚体19和四聚吲哚二芳基亚胺9,而在室温下主要得到低产率的四聚体9。通过X射线晶体学确定了六聚体19和四聚体9的结构。提出了这些寡聚反应的机理。